Structure of the Afferent Terminals in Terminal Ganglion of a Cricket and Persistent Homology

We use topological data analysis to investigate the three dimensional spatial structure of the locus of afferent neuron terminals in crickets Acheta domesticus. Each afferent neuron innervates a filiform hair positioned on a cercus: a protruding appendage at the rear of the animal. The hairs transduce air motion to the neuron signal that is used by a cricket to respond to the environment. We stratify the hairs (and the corresponding afferent terminals) into classes depending on hair length, along with position. Our analysis uncovers significant structure in the relative position of these terminal classes and suggests the functional relevance of this structure. Our method is very robust to the presence of significant experimental and developmental noise. It can be used to analyze a wide range of other point cloud data sets

Homological computation using spanning trees

We introduce here a new F2 homology computation algorithm based on a generalization of the spanning tree technique on a finite 3-dimensional cell complex K embedded in ℝ3. We demonstrate that the complexity of this algorithm is linear in the number of cells. In fact, this process computes an algebraic map φ over K, called homology gradient vector field (HGVF), from which it is possible to infer in a straightforward manner homological information like Euler characteristic, relative homology groups, representative cycles for homology generators, topological skeletons, Reeb graphs, cohomology algebra, higher (co)homology operations, etc. This process can be generalized to others coefficients, including the integers, and to higher dimension

Breast cancer and aging: results of the U13 conference breast cancer panel

Breast cancer is predominantly a disease of older women, yet there is a knowledge gap due to the persisting misalignment between the age distribution of women with breast cancer and the age distribution of participants in clinical trials. The purpose of this report is to state the U13 conference breast cancer panel’s recommendations regarding therapeutic clinical trials that will fill gaps in knowledge regarding the care of older patients with breast cancer. The U13 conference was a collaboration between the Cancer and Aging Research Group and the National Institute on Aging and the National Cancer Institute (NCI). Clinical trials should be developed for frail and vulnerable patients who would not enroll on the standard phase III trials, as well as efforts need to be made to increase enrollment of fit older patients on standard phase III trials. As a result of this conference, panel members are working with the NCI and cooperative groups to address these knowledge gaps. With the aging population and increasing incidence of breast cancer with age, it is essential to study the feasibility, toxicity, and efficacy of cancer therapy in this at-risk population

Prognostic and Biologic Relevance of Clinically Applicable Long Noncoding RNA Profiling in Older Patients with Cytogenetically Normal Acute Myeloid Leukemia

We have previously shown that expression levels of 48 long noncoding RNAs (lncRNA) can generate a prognostic lncRNA score that independently associates with outcome of older patients with cytogenetically normal acute myeloid leukemia (CN-AML). However, the techniques used to identify and measure prognostic lncRNAs (i.e., RNA sequencing and microarrays) are not tailored for clinical testing. Herein, we report on an assay (based on the nCounter platform) that is designed to produce targeted measurements of prognostic lncRNAs in a clinically applicable manner. We analyzed a new cohort of 76 older patients with CN-AML and found that the nCounter assay yielded reproducible measurements and that the lncRNA score retained its prognostic value; patients with high lncRNA scores had lower complete remission (CR) rates (P = 0.009; 58% vs. 87%), shorter disease-free (P = 0.05; 3-year rates: 0% vs. 21%), overall (OS; P = 0.02, 3-year rates: 10% vs. 29%), and event-free survival (EFS; P = 0.002, 3-year rates: 0% vs. 18%) than patients with low lncRNA scores. In multivariable analyses, the lncRNA score independently associated with CR rates (P = 0.02), OS (P = 0.02), and EFS (P = 0.02). To gain biological insights, we examined our initial cohort of 71 older patients with CN-AML, previously analyzed with RNA sequencing. Genes involved in immune response and B-cell receptor signaling were enriched in patients with high lncRNA scores. We conclude that clinically applicable lncRNA profiling is feasible and potentially useful for risk stratification of older patients with CN-AML. Furthermore, we identify potentially targetable molecular pathways that are active in the high-risk patients with high lncRNA scores

Global 3-D Simulations of the Triple Oxygen Isotope Signature Δ17O in Atmospheric CO2

The triple oxygen isotope signature Δ¹⁷O in atmospheric CO₂, also known as its “¹⁷O excess,” has been proposed as a tracer for gross primary production (the gross uptake of CO₂ by vegetation through photosynthesis). We present the first global 3-D model simulations for Δ¹⁷O in atmospheric CO₂ together with a detailed model description and sensitivity analyses. In our 3-D model framework we include the stratospheric source of Δ¹⁷O in CO₂ and the surface sinks from vegetation, soils, ocean, biomass burning, and fossil fuel combustion. The effect of oxidation of atmospheric CO on Δ¹⁷O in CO2 is also included in our model. We estimate that the global mean Δ¹⁷O (defined as Δ¹⁷O = ln( ¹⁷O + 1) − RL · ln( ¹⁸O + 1) with RL = 0.5229) of CO₂ in the lowest 500 m of the atmosphere is 39.6 per meg, which is ∼20 per meg lower than estimates from existing box models. We compare our model results with a measured stratospheric Δ¹⁷O in CO₂ profile from Sodankylä (Finland), which shows good agreement. In addition, we compare our model results with tropospheric measurements of Δ¹⁷O in CO₂ from Göttingen (Germany) and Taipei (Taiwan), which shows some agreement but we also find substantial discrepancies that are subsequently discussed. Finally, we show model results for Zotino (Russia), Mauna Loa (United States), Manaus (Brazil), and South Pole, which we propose as possible locations for future measurements of Δ¹⁷O in tropospheric CO₂ that can help to further increase our understanding of the global budget of Δ¹⁷O in atmospheric CO₂

High Log-Scale Expansion of Functional Human Natural Killer Cells from Umbilical Cord Blood CD34-Positive Cells for Adoptive Cancer Immunotherapy

Immunotherapy based on natural killer (NK) cell infusions is a potential adjuvant treatment for many cancers. Such therapeutic application in humans requires large numbers of functional NK cells that have been selected and expanded using clinical grade protocols. We established an extremely efficient cytokine-based culture system for ex vivo expansion of NK cells from hematopoietic stem and progenitor cells from umbilical cord blood (UCB). Systematic refinement of this two-step system using a novel clinical grade medium resulted in a therapeutically applicable cell culture protocol. CD56+CD3− NK cell products could be routinely generated from freshly selected CD34+ UCB cells with a mean expansion of >15,000 fold and a nearly 100% purity. Moreover, our protocol has the capacity to produce more than 3-log NK cell expansion from frozen CD34+ UCB cells. These ex vivo-generated cell products contain NK cell subsets differentially expressing NKG2A and killer immunoglobulin-like receptors. Furthermore, UCB-derived CD56+ NK cells generated by our protocol uniformly express high levels of activating NKG2D and natural cytotoxicity receptors. Functional analysis showed that these ex vivo-generated NK cells efficiently target myeloid leukemia and melanoma tumor cell lines, and mediate cytolysis of primary leukemia cells at low NK-target ratios. Our culture system exemplifies a major breakthrough in producing pure NK cell products from limited numbers of CD34+ cells for cancer immunotherapy

STIX X-ray microflare observations during the Solar Orbiter commissioning phase

Context. The Spectrometer/Telescope for Imaging X-rays (STIX) is the hard X-ray instrument onboard Solar Orbiter designed to observe solar flares over a broad range of flare sizes. Aims. We report the first STIX observations of solar microflares recorded during the instrument commissioning phase in order to investigate the STIX performance at its detection limit. Methods. STIX uses hard X-ray imaging spectroscopy in the range between 4-150 keV to diagnose the hottest flare plasma and related nonthermal electrons. This first result paper focuses on the temporal and spectral evolution of STIX microflares occuring in the Active Region (AR) AR12765 in June 2020, and compares the STIX measurements with Earth-orbiting observatories such as the X-ray Sensor of the Geostationary Operational Environmental Satellite (GOES/XRS), the Atmospheric Imaging Assembly of the Solar Dynamics Observatory, and the X-ray Telescope of the Hinode mission. Results. For the observed microflares of the GOES A and B class, the STIX peak time at lowest energies is located in the impulsive phase of the flares, well before the GOES peak time. Such a behavior can either be explained by the higher sensitivity of STIX to higher temperatures compared to GOES, or due to the existence of a nonthermal component reaching down to low energies. The interpretation is inconclusive due to limited counting statistics for all but the largest flare in our sample. For this largest flare, the low-energy peak time is clearly due to thermal emission, and the nonthermal component seen at higher energies occurs even earlier. This suggests that the classic thermal explanation might also be favored for the majority of the smaller flares. In combination with EUV and soft X-ray observations, STIX corroborates earlier findings that an isothermal assumption is of limited validity. Future diagnostic efforts should focus on multi-wavelength studies to derive differential emission measure distributions over a wide range of temperatures to accurately describe the energetics of solar flares. Conclusions. Commissioning observations confirm that STIX is working as designed. As a rule of thumb, STIX detects flares as small as the GOES A class. For flares above the GOES B class, detailed spectral and imaging analyses can be performed

Randomised, non-comparative phase II study of weekly docetaxel with cisplatin and 5-fluorouracil or with capecitabine in oesophagogastric cancer: the AGITG ATTAX trial

BACKGROUND: Docetaxel administered 3-weekly with cisplatin and 5-fluorouracil leads to better survival than does standard therapy in patients with oesophagogastric cancer, but leads to high rates of haematological toxicity. Weekly docetaxel is associated with less haematological toxicity. This randomised phase II study tested weekly docetaxel-based combination chemotherapy regimens, with the aim of maintaining their activity while reducing toxicity. METHODS: Patients with histologically confirmed metastatic oesophageal or gastric carcinoma were randomised to receive weekly docetaxel (30 mg m(-2)) on days 1 and 8, cisplatin (60 mg m(-2)) on day 1, and 5-fluorouracil (200 mg m(-2) per day) continuously, every 3 weeks (weekly TCF, wTCF); or docetaxel (30 mg m(-2)) on days 1 and 8 and capecitabine (1600 mg m(-2) per day) on days 1-14, every 3 weeks (weekly TX, wTX). RESULTS: A total of 106 patients were enrolled (wTCF, n=50; wTX, n=56). Response rates, the primary end point, were 47% with wTCF and 26% with wTX. Rates of febrile neutropenia were low in each arm. Median progression-free and overall survival times were 5.9 and 11.2 months for wTCF and 4.6 and 10.1 months for wTX, respectively. CONCLUSION: Weekly TCF and TX have encouraging activity and less haematological toxicity than TCF administered 3-weekly. Weekly docetaxel-based combination regimens warrant further evaluation in this disease

Surfactant replacement and open lung concept – Comparison of two treatment strategies in an experimental model of neonatal ARDS

Background: Several concepts of treatment in neonatal ARDS have been proposed in the last years. The present study compared the effects of open lung concept positive pressure ventilation (PPVOLC) with a conventional ventilation strategy combined with administration of two different surfactant preparations on lung function and surfactant homoeostasis. Methods: After repeated whole-lung saline lavage, 16 newborn piglets were assigned to either PPVOLC(n = 5) or surfactant treatment under conventional PPV using a natural bovine (n = 5) or a monomeric protein B based surfactant (n = 6). Results: Comprehensive monitoring showed each treatment strategy to improve gas exchange and lung function, although the effect on PaO2and pulmonary compliance declined over the study period in the surfactant groups. The overall improvement of the ventilation efficiency index (VEI) was significantly greater in the PPVOLCgroup. Phospholipid and protein analyses of the bronchoalveolar lavage fluid showed significant alterations to surfactant homoeostasis in the PPVOLCgroup, whereas IL-10 and SP-C mRNA expression was tendentially increased in the surfactant groups. Conclusion: The different treatment strategies applied could be shown to improve gas exchange and lung function in neonatal ARDS. To which extent differences in maintenance of lung function and surfactant homeostasis may lead to long-term consequences needs to be studied further